Salvage therapy for multidrug-resistant tuberculosis

Area of Science:

• Infectious Diseases
• Microbiology
• Pharmacology

Background:

• Multidrug-resistant tuberculosis (MDR-TB) treatment is challenging, especially in resource-limited settings.
• Limited options exist for patients with persistent positive sputum cultures despite second-line drugs.
• Salvage therapy combines new and existing drugs as a final treatment attempt.

Purpose of the Study:

• To evaluate the outcomes of salvage therapy in Peruvian patients with MDR-TB.
• To identify factors associated with successful culture conversion in salvage therapy.

Main Methods:

• Retrospective evaluation of 213 Peruvian patients undergoing salvage therapy for MDR-TB.
• Analysis of salvage regimen composition, including the number and types of new and previously used drugs.
• Assessment of culture conversion rates and associated factors.

Main Results:

• Culture conversion was achieved in 30.5% of patients.
• Salvage regimens included a median of two new drugs and nine total drugs.
• Moxifloxacin was the most frequently used new drug and was significantly associated with culture conversion (OR 2.2; p=0.02).

Conclusions:

• Moxifloxacin should be considered for salvage therapy and initial MDR-TB treatment to maximize cure chances.
• New TB drugs are often first used in salvage therapy cohorts.
• Close bacteriological monitoring of these patients is crucial for optimizing new drug utilization.